While randomization is required by regulatory bodies, it is up to the sponsor on how to conduct it. Developing a clinical trial’s effective monitoring plan can be overwhelming. The FDA acknowledges ...
ObservationType.FreeJointPosNoXY(obs_name="free_joint", xml_name="root", group="prioritized", allow_randomization=False), ObservationType.FreeJointVel(obs_name="free ...
Abstract: Deep neural networks are vulnerable to adversar-ial examples, they can be deceived by adding imperceptible perturbations on benign inputs. Moreover, people exploit the transferability of ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する